ESPOO, Finland, July 1st 2022. Finnish bioinformatics software company Euformatics has been awarded a grant from the European Commission’s
HELSINKI, Finland May 2022. Euformatics, BC Platforms and Oncompass Medicine formed a partnership to bid for the development of standardized
Next Generation Sequencing (NGS) relies on several quite distinct steps, all with potential effect on the patient treatment. The wet lab process,
The omnomicsNGS variant interpretation tool for annotation, classification and reporting has been upgraded to its latest version 2.7 this week in an
HELSINKI, Finland, April 2022. Viafet Genomics Laboratory, a leading laboratory in the field of human genetics in The United Arab Emirates has
HELSINKI, Finland, March 2022. Genetyca ICM SA, a leading laboratory in the field of human genetics in Portugal, has selected the Euformatics
In the wake of omnomicsNGS gaining the CE-IVD mark under the In-Vitro Diagnostics Directive (IVDD 98/79/EC), Euformatics Quality Engineer Iina